JPH11158468A5 - - Google Patents

Info

Publication number
JPH11158468A5
JPH11158468A5 JP1998274721A JP27472198A JPH11158468A5 JP H11158468 A5 JPH11158468 A5 JP H11158468A5 JP 1998274721 A JP1998274721 A JP 1998274721A JP 27472198 A JP27472198 A JP 27472198A JP H11158468 A5 JPH11158468 A5 JP H11158468A5
Authority
JP
Japan
Prior art keywords
formula
display
compound
ceremony
iid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998274721A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11158468A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH11158468A publication Critical patent/JPH11158468A/ja
Publication of JPH11158468A5 publication Critical patent/JPH11158468A5/ja
Pending legal-status Critical Current

Links

JP10274721A 1997-09-29 1998-09-29 液晶混合物 Pending JPH11158468A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE97116865.3 1997-09-29
EP97116865 1997-09-29

Publications (2)

Publication Number Publication Date
JPH11158468A JPH11158468A (ja) 1999-06-15
JPH11158468A5 true JPH11158468A5 (enExample) 2005-11-24

Family

ID=8227410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10274721A Pending JPH11158468A (ja) 1997-09-29 1998-09-29 液晶混合物

Country Status (1)

Country Link
JP (1) JPH11158468A (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1337603B1 (en) * 2000-11-29 2011-10-12 Merck Patent GmbH Electro-optical liquid crystal display and liquid crystalline medium
GB0225662D0 (en) * 2001-11-16 2002-12-11 Merck Patent Gmbh Liquid crystalline medium and liquid crystal display

Similar Documents

Publication Publication Date Title
JP2002501057A5 (enExample)
JP2001521187A5 (enExample)
BG105564A (en) Galantamine-containing composition with controlled release
YU94802A (sh) 3-prolekovi 2'-deoksi-beta-l-nukleozida
GB0117095D0 (en) "Process for the preparation of pure citalopram"
JP2002518502A5 (enExample)
JP2004057413A5 (enExample)
JPH1059711A5 (enExample)
JPH09183744A5 (enExample)
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
NZ515025A (en) Solvates of pymetrozine
EP1312319A3 (en) Orthodontic appliance
JPH11158468A5 (enExample)
EP1072596A3 (en) 4-arylpiperidine derivatives for the treatment of pruritus
AU4154799A (en) Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
EP1156058A3 (en) Process for the preparation of (E,Z) 3-(2-aminoethoxyimino)-androstane-6,17-dione and its analogues
IL141850A0 (en) HIGH PURITY COMPOSITION COMPRISING (7α,17alpha;)- 17-HYDROXY- 7-METHYL-19-NOR -17 -PREGN-5(10)-EN-20-YN-3-ONE
AU2000261384A1 (en) Porous agglomerates containing iron and at least one further element from groups5 or 6 of the periodic table for use as an alloying agent
EP1072594A3 (en) 4-arylpiperidine derivatives for the treatment of pruritus
EP1026133A3 (en) LaGaO3 sintered body
EP1072595A3 (en) 4-arylpiperidine derivatives for the treatment of pruritus
WO2005048297A3 (en) Nanostructures including a metal
USD461962S1 (en) Apparatus for displaying photographs
JP2003516751A5 (enExample)
JPH1017888A5 (enExample)